Form 4: Altimmune Director Sohn Acquires 1,000 Shares of Common Stock

Director Catherine A. Sohn of Altimmune, Inc. purchased 1,000 shares of common stock at a price of $5.7845 on March 17, 2025.

Summary

• On March 17, 2025, Catherine A. Sohn, a director of Altimmune, Inc., acquired 1,000 shares of the company's common stock.
• The purchase price was $5.7845 per share.
• Following the transaction, Ms. Sohn directly owns 1,000 shares of Altimmune's common stock.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard transaction disclosure. Insider buying is generally viewed positively, but the quantity is not significant enough to drastically alter sentiment.

Positives

• A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders. This purchase is a routine disclosure and doesn't necessarily indicate a major shift in the company's outlook.

Stakeholder Impact

• The purchase could have a slightly positive impact on shareholder sentiment.

Key Dates